The study — led by Martin Makary, MD, with the department of surgery at Baltimore-based Johns Hopkins Medicine — examined Medicare billing records for 3,248 hospitals nationwide in 2014. Researchers identified significant variation between submitted charges and the Medicare reimbursement amount across oncology specialty services.
Overall, specialty departments charged a median of up to 4.1 times more than the Medicare reimbursement amount, according to a news release. For radiology, the charge was a median of 3.7 times more, and for hematology/oncology, 2.3 times more. Medical oncology departments charged a median of 2.4 times more; radiation oncology 3.6 times more; and pathology 4.1 more.
“High markups exist for oncology services, and further legislation is needed to protect patients from highly variable pricing and to address disparities in access to high-quality cancer care,” the study’s authors concluded.
More articles on healthcare finance:
Trump’s 2019 budget blueprint: 15 healthcare takeaways
Pennsylvania hospital loses tax-exempt status: 4 things to know
North Carolina treasurer asks UNC Health Care for $1B bond to ensure cost savings from pending merger
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
